On ECHEMI
Home > Drugs > 2D Glucophosphate Chewable Tablets

2D Glucophosphate Chewable Tablets

Function and Efficacy

The calcium ions contained in this product are involved in the formation of bones and the reconstruction of bone tissue after fractures, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduce the permeability of capillaries; Vitamin B2 is a component of coenzymes and plays an important role in maintaining the integrity of the corneal epithelium and other epithelial tissues and red blood cells; Vitamin D2 mainly maintains and regulates normal blood calcium and phosphorus concentrations.

Ingredients

This product is a compound preparation. Each tablet contains 100 mg of calcium gluconate (equivalent to 9 mg of calcium), 5 mg of calcium hydrogen phosphate (equivalent to 1.14 mg of calcium), 0.092 mg of vitamin B2, and 2.3 micrograms of vitamin D2.

Name Description Content CAS NO. Manufacturer
CALCIUM GLUCONATE MONOHYDRATEIngredients

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability

More
66905-23-5 35
Calcium phosphate dibasicIngredients

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability

More
7757-93-9 16
RiboflavinIngredients

It is a component of coenzymes and plays an important role in maintaining the integrity of corneal epithelium and other epithelial tissues and red blood cells.

More
83-88-5 19
Vitamin D2Ingredients

Mainly to maintain and regulate the normal concentration of blood calcium and blood phosphorus

More
50-14-6 14

Indication

Used for calcium supplementation in children, pregnant women and lactating women

Usage and Dosage

Oral administration: Adults: 2 tablets at a time; children: 0.5~1 tablet at a time, 3 times a day, chew and take.

Adverse Reactions

1. Abdominal discomfort and constipation may occur. 2. Hypercalcemia and renal insufficiency may occur occasionally. 3. Long-term use may cause rebound increase in gastric acid secretion.

Precautions

1. It is contraindicated for patients with hypercalcemia, hypercalciuria and hypervitaminosis D. 2. It is contraindicated for patients with calcium kidney stones or a history of kidney stones. 3. It is contraindicated for patients with hyperphosphatemia and renal rickets.

Drug Interactions

1. Heart rhythm should be monitored when used with potassium-containing drugs. 2. Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Packaging Specification

Compound

Manufacturer

Xi'an Fenghua Pharmaceutical Co., Ltd.

  • Founded in:

    2004-08-17
  • Address:

    No. 15, Fengjing 1st Road, Fengjing Industrial Park, Xi'an Economic and Technological Development Zone
  • Tax NO.:

    916101257428059678
  • Registered Funds:

    10 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.